ProPhase Labs/$PRPH
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About ProPhase Labs
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
Ticker
$PRPH
Sector
Primary listing
Employees
96
Headquarters
Website
ProPhase Labs Metrics
BasicAdvanced
$4.9M
-
-$1.16
-0.68
-
Price and volume
Market cap
$4.9M
Beta
-0.68
52-week high
$0.93
52-week low
$0.10
Average daily volume
2.9M
Financial strength
Current ratio
0.141
Quick ratio
0.067
Long term debt to equity
14.065
Total debt to equity
111.995
Interest coverage (TTM)
-7.28%
Profitability
EBITDA (TTM)
-24.219
Gross margin (TTM)
19.53%
Net profit margin (TTM)
-825.00%
Operating margin (TTM)
-585.78%
Effective tax rate (TTM)
-44.14%
Revenue per employee (TTM)
$50,000
Management effectiveness
Return on assets (TTM)
-23.50%
Return on equity (TTM)
-220.34%
Valuation
Price to revenue (TTM)
0.75
Price to book
0.64
Price to tangible book (TTM)
-0.89
Price to free cash flow (TTM)
-0.355
Free cash flow yield (TTM)
-281.63%
Free cash flow per share (TTM)
-0.296
Growth
Revenue change (TTM)
-908.80%
Earnings per share change (TTM)
-22.34%
3-year revenue growth (CAGR)
-67.41%
10-year revenue growth (CAGR)
-13.44%
3-year earnings per share growth (CAGR)
-8.65%
10-year earnings per share growth (CAGR)
19.94%
What the Analysts think about ProPhase Labs
Analyst ratings (Buy, Hold, Sell) for ProPhase Labs stock.
ProPhase Labs Financial Performance
Revenues and expenses
ProPhase Labs Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ProPhase Labs stock?
ProPhase Labs (PRPH) has a market cap of $4.9M as of December 19, 2025.
What is the P/E ratio for ProPhase Labs stock?
The price to earnings (P/E) ratio for ProPhase Labs (PRPH) stock is 0 as of December 19, 2025.
Does ProPhase Labs stock pay dividends?
No, ProPhase Labs (PRPH) stock does not pay dividends to its shareholders as of December 19, 2025.
When is the next ProPhase Labs dividend payment date?
ProPhase Labs (PRPH) stock does not pay dividends to its shareholders.
What is the beta indicator for ProPhase Labs?
ProPhase Labs (PRPH) has a beta rating of -0.68. This means that it has an inverse relation to market volatility.